FGFR3 expression
|
Urothelial Cancer
|
FGFR3 expression
|
Urothelial Cancer
|
BAY 1163877 Sensitive: C3 – Early Trials
|
BAY 1163877 Sensitive: C3 – Early Trials
|
FGFR3 expression
|
Urothelial Cancer
|
FGFR3 expression
|
Urothelial Cancer
|
atezolizumab + BAY 1163877 Sensitive: C3 – Early Trials
|
atezolizumab + BAY 1163877 Sensitive: C3 – Early Trials
|